The Center for Interdisciplinary Research in Immunologic Diseases of the University of Alabama at Birmingham is a multidisciplinary effort by faculty in the Departments of Medicine, Pediatrics, Microbiology, Biochemistry, Pathology, and Cell Biology and Anatomy of the School Of Medicine. The primary goal of this CIRID program is to bring together basic and clinical investigators to develop a firm base for new scientific and clinical programs in allergic, autoimmune and immuno- deficiency diseases and to accelerate the transfer of knowledge from basic to clinical investigation. The ultimate goal is to provide better means of prevention, diagnosis, and therapy of immune system disorders. The proposed activities include basic and clinical research projects and a multi-part professional and community education program. Seven research projects in focal areas of T and B cell differentiation, autoimmunity and immunodeficiency form the basis of the CIRID program to develop and immunodeficiency form the basis of the CIRID program to develop and strengthen scientific linkage to clinical programs in allergy, asthma, and other immunologically- mediated diseases. The projects focus on the potential roles of novel T cell subpopulations, MHC class III genes, Vh gene rearrangement, and regulation of galactosyltransferase activity in autoimmunity and immunodeficiency, the role of antigens in pattern selection of B cell repertoire during ontogeny and following bone marrow transplantation, and the influence of DNA topology in isotype switching, The unifying theme for these related research projects is to link animal and human studies of the immune system at both molecular and cellular levels. We hold to the thesis that studies of the basic immune response, regardless of the immunoglobulin class or cell type under investigation, have relevance to all applied and clinical branches of this intricate system of defense.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
5P50AI023694-06
Application #
3105082
Study Section
Allergy & Clinical Immunology-1 (AITC)
Project Start
1986-09-30
Project End
1994-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
6
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Bertrand 3rd, F E; Billips, L G; Burrows, P D et al. (1997) Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow. Blood 90:736-44
Wu, J; Wilson, J; He, J et al. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98:1107-13
Su, X; Zhou, T; Yang, P A et al. (1996) Hematopoietic cell protein-tyrosine phosphatase-deficient motheaten mice exhibit T cell apoptosis defect. J Immunol 156:4198-208
Zhou, T; Edwards 3rd, C K; Yang, P et al. (1996) Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J Immunol 156:2661-5
Zhou, T; Cheng, J; Yang, P et al. (1996) Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J Exp Med 183:1879-92
Mountz, J D; Cheng, J; Su, X et al. (1995) Autoimmunity, apoptosis defects and retroviruses. Adv Exp Med Biol 374:183-201
Cheng, J; Liu, C; Koopman, W J et al. (1995) Characterization of human Fas gene. Exon/intron organization and promoter region. J Immunol 154:1239-45
Liu, C; Cheng, J; Mountz, J D (1995) Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem J 310 ( Pt 3):957-63
Mountz, J D; Zhou, T; Long, R E et al. (1994) T cell influence on superantigen-induced arthritis in MRL-lpr/lpr mice. Arthritis Rheum 37:113-24
Reaban, M E; Lebowitz, J; Griffin, J A (1994) Transcription induces the formation of a stable RNA.DNA hybrid in the immunoglobulin alpha switch region. J Biol Chem 269:21850-7

Showing the most recent 10 out of 31 publications